Suche
Filter by content type
Filter by content year
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
April 29, 2020 - … facilities in Europe. BioNTech is collaborating with Fosun Pharma to develop BNT162 in China, where the companies … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; and …
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
September 15, 2020 - … is being co-developed with its partners Pfizer Inc. and Fosun Pharma respectively. The goal of the initiative is the … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … is being co-developed with its partners Pfizer Inc. and Fosun Pharma respectively. The goal of the initiative is the …
BioNTech Recognizes Employees and Partners for Their Support in Developing Historic Vaccine
Dezember 31, 2020 - … Fisher Scientific Novartis Sino Biological Europe Biaffin Fosun Pharma ONE LOGIC Sinus Event-Technik BioCat … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … Fisher Scientific Novartis Sino Biological Europe Biaffin Fosun Pharma ONE LOGIC Sinus Event-Technik BioCat …
BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
April 22, 2020 - … facilities in Europe. BioNTech is also collaborating with Fosun Pharma to develop BNT162 in China, where the companies … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; the …
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
Mai 5, 2020 - … (excluding China, where BioNTech has a collaboration with Fosun Pharma for BNT162 for both clinical development and … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; and …
BioNTech Announces Full Year 2019 Financial Results and Corporate Update
März 31, 2020 - … oncology pipeline and, along with our partners Pfizer and Fosun Pharma, aim to dose the first patient with our COVID-19 … shortly. BioNTech also announced a strategic alliance with Fosun Pharma to develop its COVID-19 vaccine in China. Under … China, conducting clinical trials in China and leveraging Fosun Pharma’s extensive clinical development, regulatory, …
BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
Dezember 2, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Hold Press Conference to Provide an Update on COVID-19 Vaccine Development Program
Dezember 21, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Report Second Quarter 2020 Financial Results and Operational Update on August 11, 2020
August 6, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …
BioNTech to Report Third Quarter 2020 Financial Results and Operational Update on November 10, 2020
November 3, 2020 - … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … a member of the Roche Group, Regeneron, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …